| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |